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THE TREATMENT OF PULMONARY TUBERCULOSIS
J. B. PORTEOUS, Deputy Medical Superintendent, Brooklyn Hospital for Chest Diseases, Maitland
The treatment of pulmonary tuberculosis may be likened to
a pendulum which swings from one extreme to the other over
the years, and which, during the last 10 years, has been passing
through a phase in which the disease is treated with an ever-
increasing number of antituberculous drugs. With every
month that passes new variants are being added to the tried
favourites; new techniques of administration are being
advocated, and still newer drugs are being added to the list.
This clinical appraisal is presented in the hope that it may
shed some light on present-day drugs and regimes of adminis-
tration.
Apart from the general principles involved in the treatment
of any infectious disease viz. isolation, rest and feeding, it is
now possible to assess more accurately the value of the
various antituberculous drugs and to advocate certain lines
of treatment based on world-wide experience. .
DRUG THERAPY
Whatever drugs are selected, the patient's response to these
should be backed up by clinical, laboratory and radiological
assessment. It is useless to use a certain drug because it has a •
tuberculostatic or tuberculocidal effect-the aim must be
eradication of the, infection with the best possible means
available. In general, drug therapy falls into two main
sections: (1) that dealing with the known and proved agents,
and (2) that dealing with the newer agents.
1. KnOlvn andProvedAgents
It is generally accepted that streptomycin, isonicotinic acid
hydrazide (!NAB) and para-aminosalicylic acid (PAS)
should be used in the treatment of pulmonary tuberculosis.
Their effect, dosage and method of administration have been
the subject of numerous papers and it is possible now to
advocate an optimal regime. But, although these drugs are
the therapeutic agents of choice, they have certain disadvan-
tages because (1) they can all produce a resistant strain of
tubercle bacilli and (2) they all produce symptoms of toxicity
or allergy in the patient.
Streptomycin. Recent research into the emergence of
resistant strains of bacilli produced by the intermittent
method of admihistration have shown that the most effica-
cious way to give this drug is to give daily doses of 1 g. by
deep intramuscular injection. Emergence of resistant strains
which could develop in 6 weeks under the old regime of 1 g.
twice weekly has been abolished or delayed for longer periods
by this method. It is also widely accepted, on the basis of
controlled experiments, that this drug should never be used
alone-the combination streptomycinjINAH or strepto-
mycinjPAS is more effective than the administration of each
drug 00 its own.
The following toxic effects may occur: (1) Permanent
damage to the auditory branch of the VIII nerve. This occurs
in 6-10% of all cases treated. In certain individual the
vestibular branch of the VIII nerve may be affected, leadiog
to a disturbance of the proprioceptive sense. This is, however,
now rare, since purification of the drug has eliminated what
used to be a erious consequence of its administration.
The dihydrosalt appears to have greater toxicity for the
hearing mechanism. (2) Sensitization phenomena such a
skin rashes still occur and sometimes prove troublesome.
They are best treated by withdrawal, antihistaminics and test
doses to determine whether streptomycin is really responsible.
(3) Agranulocytosis has been reported.
Isonicotinic acid hydrazide (INAH). Initially administered
alone, it is now widely recognized that this practice leads
to rapid development of resistant strains, consequenUy
INAR is always given in combination with either strepto-
mycin or PAS or both. It is also being used in conjunction
with some of the newer drugs. The optimal dosage can be
regarded as between 3-5 mg. per kg. of body weight per day,
given orally in divided doses. Absorption is very rapid.
Parenteral administration leads to peak levels in pleural and
cerebrospinal fluids and tissues more rapidly than oral intake.
The principal toxic manifestation has been a peripheral
neuritis, the symptoms of which resemble those of a vitamin
B6 (pyridoxine) deficiency. These effects are noted when doses
higher than 5 mg. per kg. of body weight are employed;
but they may appear in certain individuals at lower dosage
levels. INAR is recognized as having some effect on carbo-
hydrate metabolism, and various types of interference with
the utilization of sugars, particularly in diabetics, have been
reported. Allergic manifestations do occur, as with many
other drugs; but these have not proved of great moment.
Para-aminosalicylic acid (PAS) is at present used almost
exclusively in association with other more potent antimicro-
bial agents such as streptomycin and INAR. Although it
may be employed intravenously, intramuscularly, intra-
pleurally, or even intrathecally, oral dosage proves the most
practical. The optimum dosage lies between 10-15 g. per
day (average 12 g. per day) in divided do es. Strains of
resistant bacilli develop in patients treated with this drug;
but emergence of these strains is slow and treatment can be
carried on for months or years.
The most common toxic effect is digestive disturbance-
anorexia, nausea, vomiting and diarrhoea. In certain indivi-
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duals these may be of such magnitude as to require cessatIOn
of therapy. Other more serious side-effects are hypokalaemia,
a goitrogenic effect, severe allergic reaction and signs of
liver damage as shown by reduction in blood prothrombin
and cholesterol, and by jaundice. These effects require
withdrawal of the drug and change to another regime.
Combinations of Treatment. As each of the above drugs
was discovered, it was used alone, and like all new weapons
proved effective initially, but i soon lost that effectiveness
through the emergence of drug resistance. Various investi-
gators tried different combinations of these drugs, and it is
now accepted: that (I) streptomycin-INAH is the most
effective combination; that (2) streptomycin-PAS is useful in
long-term policy; that (3) Streptomycin-PAS-INAH is now
probably the most useful combination and the least likely
to cause the emergence of drug resistant strains in the pre-
viously untreated individual and that (4) I AH-PAS can be
given to cases where long-term drug cover is required, or
where the facilities do not exist to give daily injections.
When using combina'ions of these 3 drugs, it is essential
to request regular laboratory tests for the emergence of drug
resistance ill the organisms. In this way, time is not wasted
in continuing treatment regimes which are ineffective. and
at the earliest possible moment, a change can be made to a
drug, or combination of drugs, to which the bacilli have not
been previously exposed..
2. Newer Agents
In considering the drugs listed below it is as well to bear in
mind that these, while having tuberculostatic properties,
are not to be regarded as more efficacious than the first
group. By comparison they are less potent than streptomycin
or combined therapy-and in some cases are more toxic.
They can advantageously be employed, after drug resistance
to streptomycin-INAH or streptomycin-PAS has emerged,
for a period of several weeks or even months, to try to elimi-
nate the resistant bacilli from the host-a cha:nge back to the
streptomycin-INAH or streptomycin-PAS regime may then
be made. The determining factor in the prolonged use of these
'intermediate' drugs is their toxic effect on the host.
Penicillin is ineffective against tubercle bacilli but is men-
tioned because in pyogenic complications of the disease,
e.g. empyema, it exerts its usual beneficial action on sup-
purative infections.
Oxytetracycline. Good results have been reported in
clinical treatment with oxytetracycline in conjunction with
streptomycin. Its effectiveness appears to be like that of PAS
in delaying the emergence of resistance to streptomycin.
Its main drawback is the high (±4 g. per day) dosage and
attendant intes tinal upset.
Viomycin is employed by some in the re-treatment of cases
after unsatisfactory results with other drugs, rather than in the
initial therapy of tuberculosis. Its use is thus restricted to
cases where neither streptomycin nor INAH can be used to
advantage beCause of intolerance to these agents or high
degrees of bacterial resistance. Some success has attended its
use in this way; but its dosage and effectiveness are limited by
its toxicity. Its unfavourable action is manifested by head-
ache, nausea and other symptoms of malaise.
Cycloserine is apparently less active than either strepto-
mycin or INAH, but it has been reported effective as a single
medicament in patients not previously treated with chemo-
therapy. Combined with standard daily doses of INAH or
2 g. of streptomycin per week it has led to definite improve-
ment in patients whose clinical course was unfavourable on
other regimes. In doses of O· 5 g. daily combined with 4 mg.
of I AH Per kg. of body weight per day, it constitutes
an effective therapeutic regime of low toxicity.
Drug resistance occurs as rapidly, and to the same degree
as in streptomycin and INAH and has been correlated with
loss of clinical effectiveness. Toxic effects are p~ychogenic
reactions in patients wHh psychotic backgrounds, hyper-
refiexia and mild epileptiform convulsions. The convul-
sions seem directly related to the size of the dose.
SURGICAL PROCEDURES
In a discussion of the treatment of pulmonary tuberculosis
mention must be made of the part played by minor and major
surgical procedures in the control of the disease.
Minor surgical procedures (collapse therapy). These pro-
cedures have to a large extent fallen into disuse through the
effectiveness of chemotherapy but they should not be com-
pletely disregarded in the scheme of treatment since they may
hasten the ultimate aim-that of control.
In brief they are: (I) phrenic crush, (2) artificial pneumo-
thorax and (3) artificial pneumoperitoneum. These proce-
dures are all aimed at influencing the disease process in the
affected lung.
Major surgical procedures are widely employed and are
directed towards effecting a permanent cure by removal of
diseasyd tissue. They are all employed after a reasonable
time has been devoted to chemotherapy and are followed by
at least 12 months further chemotherapy. The operations
performed range from (a) segmental resection of a portion of
a lobe, to (b) lobectomy, and/or (c) pneumonectomy, followed
• by (d) thoracoplasty.
Modern anaesthesia and post-operative care have reduced
the mortality and it is possible for bilateral surgery to be
carried out on cases which were, some 10 years ago, regarded
as hopeless. Not every case of pulmonary tuberculosis can,
however, be regarded as suitable for surgery; the selection ('If
cases requires thorough investigation and consideration by a
team of physicians and surgeons.
COMMO COMPLICATIONS
The following are some of the common complications
which occur during the course of the illness and brief notes
on their treatment.
1. Cough. Unproduttive irritating cough can be con-
trolled in many cases by the use of expectorant mixtures,
inhalations, or in the worst cases, by the administration of
romilar, or a similar' product. Productive cough should not
be suppressed, but great relief from exhausting spasms can
be obtained by postural drainage.
2. Haemoptysis is a most alarming symptom which usually
responds to a subcutaneous dose of 1/6---1/4 gr. of mor-
phia, followed by a sedative mixture such as mist. pot. bromo
et chloral ~ fir oz. 4 hourly. In mild blood-staining of the
sputum, the sedative mixture and strict bed rest may be
sufficient to control the bleeding.
If the bleeding is more than staining of the sputum, it is
better to give the morphia and at the same time administer
one of the following coagulants: Adrenosem 2 C.C. intra-
muscularly or 2· 5 mg. orally, or adrenoxyl in similar doses
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(these two preparations may be given 4 hourly)· koagamin
3 c.c. intravenously followed by 2 c.c. intramuscularly 2
hourly up to a total of 10-15 c.c. or Congo red 1% lO c.c.
intravenously.
Only in the most severe cases is transfusion necessary and
then the blood should be given slowly, because too rapid
administration may cause a rise in blood pressure and start
the haemoptysis again.
3. Diabetes me/litus. This is a common complication of
pulmonary tuberculosis and often proves difficult to control.
It is best treated by giving soluble insulin since the insulin
requirements of the patient vary with the progress of the
lung disease, and stabilization is best effected by using a
short-acting insulin while the lung disease is active. Once
the lung disease has settled down it is usually possible to
switch to a medium-acting insulin; while in a few cases, a
long-acting preparation may be used once the patient has
returned to work. •
4. Drug rashes are of infinite variety and may prove
extremely troublesome. They are usually associated with
streptomycin sensitivity- and are best treated by withdrawal
of all drugs and the administration of antihistarninics.
Once the rash has been controlled, each drug is restarted
separately while careful watch is kept for the reappearance of
the rash. Desensitization can be attempted but may be
nullified b the appearance of drug-re i tant bacilli. The
elimination of the offender i , therefore the afi t procedure
to adopt; other drug combimition an then be tried:
5. SpoTllaneous pneumothorax, if udden and ma ive, may
lead to death from mediastinal hifr. Preliminary needling of
the air pace and the taking of manometric pre sures after
the withdrawal of some air, will indicate, by the failure to
maintain a negative pre ure after a piration, whether a
fistula i pre ent. In this case intubation and underwater
drainage is neces ary. If a negative pre ure is maintained,
expectant treatment canbe adopted.
6. Pleural effusion may cause severe di tres if there is a
ma sive accumulation. eedling and a piration of a ample
of fluid should be done early. If the fluid is traw-coloured
and clear, aspiration by syringe until no more can be with-
drawn, is indicated. If the fluid is at all hazy or turbid the
presence of an empyema is indicated. Intubation with an
underwater drain is now the method of choice for the pus
must be drained. Daily instillations of 1 g. of streptomycin
and 1 mega of penicillin are indicated until the underlying
lung has fully expanded. If this does not occur, major
surgery-decortication-is the next step.
7. Pericardial effusion may be a distressing complication
and requires aspiration with the instillation of streptomycin
and penicillin.
PROTEUS INFECTIONS SUCCESFULLY TREATED IN "GENERAL PRACTICE
WITH BICILLIN AND STREPTOMYCIN
DAVID PELKOWITZ, M.B., RCH., Johannesburg
Case 1. About 6 years ago (1952) a case of very severe
vaginitis and inguinal adenitis was seen (Mrs. V.R.). Fever
was present and evidence of toxaerni·a. The patient was
listless and weak and had a profuse vaginal discharge with
pains in both groins. As this was an unusually severe vagini-
tis, swabs were taken; culture showed a profuse growth of
B. proteus. The swabs were repeated and again a culture of
B. proteus was obtained. As a result of the sensitivity tests, .
treatment with erythrocin was suggested, though the tests
showed the organism to be only slightly sensitive to this
antibiotic. The patient had already been started on Bicillin,
1,200,000 units daily. For a few days, her condition remained
unchanged; then after the 5th day there was a slow but
steady improvement and in 1 weeks the case had cleared up.
The only antibiotics used were Bicillin and erytbrocin.
In view of the heavy penicillin dosage (a total of about
17,000,000 units of long-acting penicillin in daily doses
over 2 weeks) I thought it would be worth while to test
the B. proteus against stronger quantities of penicillin in
the routine sensitivity tests. My idea was that heavy dosage
with long-aating penicillin maintained for a long spell (about
2 weeks) would destroy B. proteus, even though routine
sensitivity tests always showed B. proteus to be insensitive
to penicillin. The clinical pathologist was therefore asked
to use up to 500 units in the test instead of the routine 100.
I wished to determine which of the antibiotics used was
responsible for tpe satisfactory result achieved. The modified
sensitivity test showed that B. proteus was extremely sensitive
to the 500 strength penicillin used.
It is commonly recognized that B. proteus is a highly
resistant organism, and it was a surprise to find it sensitive
to the 500 unit penicillin test. The Bicillin treatment was
therefore followed up in later cases of B. proteus infection.
It was hoped that massive dosage would assist body defence •
mechanisms (enzymes, phagocytes and antibodies) which
are absent in the in vitro test, to fight against this highly
resistant organism. It is known what trouble this organism
can cause, and how difficult if,- is to ~radicate, especially
in vaginitis and adenitis.
Case 2. The next case was seen about 5 months later-an
elderly lady (Mrs. L.M.) with a chronic intractable colitis
of long standing and apparently incurable. She gave a
history of severe attacks of diarrhoea, colic and pruritus.
X-rays had previously revealed diverticulitis. Stool culture
gave profuse growth of B. proteus and a further specimen
confirmed the existence of the organism. A course of Bicillin
therapy was instituted. The first week the improvement
was slow, but during the second week the patient was much
more comfortable, and symptoms settled down; the number
of stools was much less and colic and pruritus were much
improved. Culture now gave a scanty growth, and the next
culture no growth at all. The organism was not ensitive
to penicillin in the usual ill vitro sen itivity tests, but when
500 units were used it ~as definitely sensitive.
Case 3. A further case of vaginitis and inguinal gland
then cropped up (Mr. l.P.). Treatment with pessaries
and ulphonamides failed to achieve an improvement.
Swabbing revealed B. proteus and the 2-week cour e of
Bicillin wa tarted. Once again the result wa very good.
